Home exoskeleton for walking after spinal cord injury
Tests the ABLE Daily exoskeleton for walking at home in adults with spinal cord injury.
Key facts
- Who runs it
- ABLE Human Motion S.L.
- Where
- Netherlands1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Exoskeleton Training at Home to Assist Participants With Spinal Cord Injuries to Perform Ambulatory Functions.
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 19 Jun 2025
- Planned end
- 30 Oct 2026
- Type of study
- Interventional
- Treatments tested
- ABLE Daily
- Record updated
- 2 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a long-standing spinal cord injury who can already walk with the ABLE Exoskeleton. They will train with the ABLE Daily robotic suit and then use it at home for 12 weeks.
- Age
- 18 years or older.
- Sex
- All sexes can join.
- Disease stage
- Chronic spinal cord injury for more than 6 months, at levels T1 to L5 (AIS A to D). Walking Index for Spinal Cord Injury (WISCI) score 0 until 9.
- Earlier treatment
- People must already walk well with the ABLE Exoskeleton. For at least 8 weeks before the start, they must have had little use (less than 5 sessions) of wearable walking robots.
Main reasons for not taking part
- High risk of broken bones from osteoporosis (weak bones) on a DEXA bone scan, or fragile-bone fractures of the legs in the last 2 years.
- Spinal instability, such as spondylolisthesis, or arm and hand problems that make walking with crutches impossible.
- Body size outside 150-200 cm (4 ft 11 in–6 ft 7 in) height or 100 kg (220 lb) weight or more, or other body limits that do not fit the device.
- Heart or blood vessel problems that prevent training, or not able to stand 10 minutes without low blood pressure symptoms.
- Known pregnancy.
The registry criteria, word for word
Show all 25 criteriaShow less
Who can take part
- At least 18 years old
- Chronic SCI (>6 months)
- Injury at levels T1 to L5 (AIS A to D)
- Walking Index for Spinal Cord Injury (WISCI) score 0 until 9
- Height between 150-200 cm
- Weight less than 100 kg
- Capable of giving informed consent on their own
- Able to train (at least) 3 days/week
- Able to have at least 1 companion / buddy who can attend a minimum of two of the training sessions, besides the final assessment, and who will learn how to assist them at home and in the community (ideally two companions)
- Proficiency in walking with the ABLE Exoskeleton
- At least 8 weeks with minimal use (less than 5 sessions) of wearable robotic exoskeletons for gait assistance at the start of the study
Who cannot take part
- Disorders of the arms and hands that make walking with crutches impossible
- Psychological, cognitive issues, or any other condition that does not allow a participant to follow study procedures
- Medically unstable due to severe comorbidities, including any condition that a physician deems inappropriate for completing study participation
- High risk of fractures due to osteoporosis, a dual energy X-ray absorptiometry (DEXA)-scan at the hip, distal femur, and proximal tibia BMD score
- Fragility fractures of the lower limbs in the last 2 years
- Deterioration >3 in the International Standards for Neurological Classification of SCI (ISNCSCI) score in the last 4 weeks
- Spinal instability, like spondylolisthesis
- Modified Ashworth Scale (MAS) >3 in lower limbs
- Cardiovascular health issues which prevent the participant from training
- Instability to tolerate 10 minutes of standing without clinical symptoms of orthostatic hypotension
- Skin problems in areas that would be in contact with the device
- Height, width, weight, or other anatomical limitations (such as differences in leg length) incompatible with the device
- Insufficient joint range of motion (ROM) for the device
- Known pregnancy
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to to confirm the safety and performance of the ABLE Daily to perform ambulatory functions in home and community settings for people with spinal cord injury.
Read full original descriptionShow less
The experimental period will cover the training period with the ABLE Daily exoskeleton (3 weeks of use at the investigational site with a total of 9 sessions) and the home period (12 weeks of personal use at home and community environments).
The group in the trial
- Intervention with exoskeletonTreatment being tested
The participants will receive training sessions with the ABLE Daily at Sint Maartenskliniek. After they pass the skills and knowledge exam, they will receive the ABLE Daily at their disposal at home for twelve weeks.
Treatment: ABLE Daily
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Clinical Investigation on the Safety and Performance of the ABLE Daily to Assist People With Spinal Cord Injury in Performing Ambulatory Functions in Home and Community Settings
- Plain-language title
- Home exoskeleton for walking after spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 2 June 2026